Citation Impact
Citing Papers
Guidelines for red blood cell and plasma transfusion for adults and children
1997
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Point-of-Care Testing
2012 Standout
Meta-Analysis Comparing the Effectiveness and Adverse Outcomes of Antifibrinolytic Agents in Cardiac Surgery
2007
Anticoagulation Management in a Patient with an Acquired Antithrombin III Deficiency
2001
Review of the clinical practice literature on allogeneic red blood cell transfusion
1997
The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
2000
Parenteral Anticoagulants
2012 Standout
Antithrombin III in Cardiac Surgery: An Outcome Study
1998
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
2004 Standout
Re-graft patency and clinical efficacy of aprotinin in elective bypass surgery
1997
Aprotinin for coronary artery bypass grafting: Effect on postoperative renal function
1995
Management of Bleeding Complications in Redo Cardiac Operations
1998
Aprotinin Versus Lysine Analogues: The Debate Continues
1998
Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass
1995
The Dose-Response Relationship of Tranexamic Acid
1995
Strict Thermoregulation Attenuates Myocardial Injury During Coronary Artery Bypass Graft Surgery as Reflected by Reduced Levels of Cardiac-Specific Troponin I
2003
Antifibrinolytic drugs and perioperative hemostasis
1997
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Role of Antioxidants and Natural Products in Inflammation
2016 Standout
A randomized trial of antithrombin concentrate for treatment of heparin resistance
2000
Drugs to Minimize Perioperative Blood Loss in Cardiac Surgery
1997
Aprotinin Reduces Blood Loss in Patients Undergoing Elective Liver Resection
1997
Combined aprotinin and erythropoietin use for blood conservation: Results with Jehovah's Witnesses
1994
Topical use of aprotinin in open heart operations
1993
Clinical Outcomes in Cardiac Surgery: Conventional Surgery versus Bloodless Surgery
2005
Anatomical, Histologic, and Genetic Characteristics of Congenital Chest Wall Deformities
2009 Standout
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
1999 Standout
Perioperative Management of Antithrombotic Therapy
2012 Standout
High-Dose ϵ-Aminocaproic Acid Versus Aprotinin: Antifibrinolytic Efficacy in First-Time Coronary Operations
1998
Postoperative antithrombin levels and outcome in cardiac operations
2005
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Cell salvage for minimising perioperative allogeneic blood transfusion
2006
Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass
1993
Release of TNF-α during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers
2003
Aprotinin and recombinant human erythropoietin reduce the need for homologous blood transfusion in cardiac surgery
1998
A review of transfusion risks and optimal management of perioperative bleeding with cardiac surgery
2008
Aprotinin Decreases Exposure to Allogeneic Blood During Primary Unilateral Total Hip Replacement*
2000
Safety of Transesophageal Echocardiography
2010
A Double-Blind, Placebo-Controlled Trial of Epsilon-Aminocaproic Acid for Reducing Blood Loss in Coronary Artery Bypass Grafting Surgery
2005
Comparative Effects of Small and Large Aprotinin Doses on Bleeding During Orthotopic Liver Transplantation
1995
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
A new method of measuring heparin levels in whole blood by protamine titration using a heparin-responsive electrochemical sensor
1996
Hemostatic Drugs
1998
A Meta-Analysis of the Effectiveness of Cell Salvage to Minimize Perioperative Allogeneic Blood Transfusion in Cardiac and Orthopedic Surgery
1999
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
Tranexamic Acid
1999 Standout
Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest
2010
Activity‐based costs of blood transfusions in surgical patients at four hospitals
2009 Standout
Kidney-specific proteins in patients receiving aprotinin at high- and low-dose regimens during coronary artery bypass graft with cardiopulmonary bypass
2005
Effects of high-dose aprotinin on renal function in aortocoronary bypass grafting
1995
Randomized, Placebo-Controlled, Double-Blind Study of an Ultra-Low-Dose Aprotinin Regimen in Reoperative and/or Complex Cardiac Operations
1997
The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis
2008
Influence of High-dose Aprotinin on Anticoagulation, Heparin Requirement, and Celite- and Kaolin-Activated Clotting Time in Heparin-pretreated Patients Undergoing Open-Heart Surgery
1995
The Efficacy of Antifibrinolytics in the Reduction of Blood Loss During Complex Adult Reconstructive Spine Surgery
2001
Aprotinin Decreases Blood Loss in Patients Undergoing Revision or Bilateral Total Hip Arthroplasty
1995
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints
1999
Die Wirkung von Aprotinin
1997
Platelet function during cardiac surgery and cardiopulmonary bypass with low-dose aprotinin
1999
Platelet protection by low-dose aprotinin in cardiopulmonary bypass: Electron microscopic study
1993
Discovery of curcumin, a component of golden spice, and its miraculous biological activities
2011 Standout
Effects of aprotinin on hemorrhagic complications in ARDS patients during prolonged extracorporeal CO2 removal
1992
The Impact of Aprotinin on Coronary Artery Bypass Graft Patency
1994
Restoration of the Normal Coagulation Process: Advances in Therapies to Antagonize Heparin
1996
Influence of aprotinin on early graft thrombosis in patients undergoing myocardial revascularization
1994
Aprotinin Reduces Cardiac Troponin I Release and Inhibits Apoptosis of Polymorphonuclear Cells During Off-Pump Coronary Artery Bypass Surgery
2007
The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm
2017 Standout
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
2011 Standout
The Preventative Role of Curcumin on the Lung Inflammatory Response Induced by Cardiopulmonary Bypass in Rats
2011
Acute respiratory distress syndrome
2019 Standout
Economic evaluation of high-dose and low-dose aprotinin therapy during cardiopulmonary bypass
1999
The effects of aprotinin and steroids on generation of cytokines during coronary artery surgery
2001
Ultrafiltration reduces blood transfusions following cardiac surgery: a meta-analysis
2006
Does Acute Normovolemic Hemodilution Reduce Perioperative Allogeneic Transfusion? A Meta-Analysis
1998
Role of blood cells in ischaemia-reperfusion induced endothelial barrier failure
2010
Amelioration of the bleeding tendency of preoperative aspirin after aortocoronary bypass grafting
2000
Early Coagulopathy Predicts Mortality in Trauma
2003 Standout
The Efficacy of Aprotinin in Arterial Switch Operations in Infants
2008
Heparin-induced thrombocytopenia and cardiac surgery
2003 Standout
Effect of Reduced Aprotinin Dosage on Blood Loss and Use of Blood Products in Patients Undergoing Cardiopulmonary Bypass
1993
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Adverse effects of methods for minimizing perioperative allogeneic transfusion: A critical review of the literature
1998
Elimination of Recombinant Hirudin by Modified Ultrafiltration During Simulated Cardiopulmonary Bypass: Assessment of Different Filter Systems
2000
The impact of ischaemia–reperfusion on the blood vessel
2009
Lower cardiac troponin T levels in patients undergoing cardiopulmonary bypass and receiving high-dose aprotinin therapy indicate reduction of perioperative myocardial damage
1995
Natural and synthetic antifibrinolytics in adult cardiac surgery: efficacy, effectiveness and efficiency
1994
Modified Ultrafiltration Reduces Morbidity After Adult Cardiac Operations
2001
Warfarin pretreatment does not lead to increased bleeding tendency during cardiac surgery
1995
The Effect of Epsilon-Aminocaproic Acid and Aprotinin on Fibrinolysis and Blood Loss in Patients Undergoing Primary, Isolated Coronary Artery Bypass Surgery: A Randomized, Double-Blind, Placebo-Controlled, Noninferiority Trial
2009
Consensus Review of Optimal Perioperative Care in Colorectal Surgery
2009 Standout
Aprotinin But Not ε-Aminocaproic Acid Decreases Interleukin-10 After Cardiac Surgery With Extracorporeal Circulation
2001
Aprotinin, Blood Loss, and Renal Dysfunction in Deep Hypothermic Circulatory Arrest
2001
The inflammatory response in myocardial injury, repair, and remodelling
2014 Standout
Aprotinin reduces blood loss in off-pump coronary artery bypass (OPCAB) surgery
2002
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
1999
Treatment of Persistent Gross Hematuria with Tranexamic Acid in Autosomal Dominant Polycystic Kidney Disease
2017 Standout
Influence of High- and Low-Dose Aprotinin on Activation of Hemostasis in Open Heart Operations
1998
CLINICAL APPLICATION OF ARGATROBAN AS AN ALTERNATIVE ANTICOAGULANT FOR EXTRACORPOREAL CIRCULATION
2000
CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
2011 Standout
Low-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients
1993
Cell salvage for minimising perioperative allogeneic blood transfusion
2010
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
cardiopulmonary bypass in patients?
2003
Autologous platelet sequestration in patients undergoing coronary artery bypass grafting
1996
Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence
2004
Treating Heparin Resistance With Antithrombin or Fresh Frozen Plasma
2008
Cell salvage for minimising perioperative allogeneic blood transfusion
2003
Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of ϵ-aminocaproic acid and aprotinin
2003
Reduced blood loss by aprotinin in thoracic surgical operations associated with high risk of bleeding. A placebo-controlled, randomized phase IV study
2001
Management of Abdominal Aortic Aneurysms Clinical Practice Guidelines of the European Society for Vascular Surgery
2011 Standout
Reduction in blood loss and blood use after cardiopulmonary bypass with high-dose aprotinin versus autologous fresh whole blood transfusion
1992
Efficacy of Aprotinin in Different Doses and Autologous Blood Transfusions in Cardiac Surgery
1994
Hemofiltration during Cardiopulmonary Bypass for High Risk Adult Cardiac Surgery
2003
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2016 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations
1994
Efficacy and safety of aprotinin in aortocoronary bypass and valve replacement operations: a placebo-controlled randomized double-blind study
1996
The relative contributions of antithrombin iii during heparin treatment, and of clinically recognisable risk factors, to early recurrence of venous thromboembolism.
1987
Anticoagulation Monitoring during Cardiac Surgery
1999
Comparaison des effets de l’aprotinine et de l’acide tranexamique sur le saignement en chirurgie cardiaque
1995
Effect of aprotinin (Trasylol) on aorta-coronary bypass graft patency
1993
Drugs to Minimize Perioperative Blood Loss in Cardiac Surgery
1997
Aprotinin Reduces Blood Loss in Patients Undergoing Elective Liver Resection
1997
Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study
1992
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial
2011 Standout
Low factor XIIIA levels are associated with increased blood loss after coronary artery bypass grafting
1994
Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. A multicenter, randomized, double-blind, placebo-controlled study.
1994
Is ε-Aminocaproic Acid as Effective as Aprotinin in Reducing Bleeding With Cardiac Surgery?
1999
Intraoperative Hemofiltration in Adults: Prevention of Hypercirculatory Syndrome?
2005
Effects of hemofiltration on serum a protinin levels in patients undergoing cardiopulmonary bypass
2000
Plasma sRAGE enables prediction of acute lung injury after cardiac surgery in children
2012
Comparison of two doses of aprotinin in patients receiving aspirin before coronary bypass surgery
2000
Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease
2013
Different patterns of heparin resistance: therapeutic implications
2002
Effects of Unprocessed and Processed Cardiopulmonary Bypass Blood Retransfused into Patients after Cardiac Surgery
1999
Randomized placebo-controlled double-blind study of three aprotinin regimens in primary cardiac surgery
1994
Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting
1994
New Anticoagulants for the Cardiovascular Patient
1995
A Multicenter, Double-Blind, Placebo-Controlled Trial of Aprotinin for Reducing Blood Loss and the Requirement for Donor-Blood Transfusion in Patients Undergoing Repeat Coronary Artery Bypass Grafting
1995
The Safety and Efficacy of “Bloodless” Cardiac Surgery
2005
Effect of Aprotinin on Plasma Fibronectin Levels During Cardiopulmonary Bypass
1997
Malignant pectus excavatum
2006
Rekombinantes Hirudin als Antikoagulans für den kardiopulmonalen Bypass in der Herzchirurgie: Klinische Erfahrungen
1997
Carrier-Based Ion-Selective Electrodes and Bulk Optodes. 2. Ionophores for Potentiometric and Optical Sensors
1998 Standout
A Meta-Analysis of the Effectiveness of Cell Salvage to Minimize Perioperative Allogeneic Blood Transfusion in Cardiac and Orthopedic Surgery
1999
Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding?
2005
Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass
1994
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
2010 Standout
Effects of hemofiltration on serum aprotinin levels in patients undergoing cardiopulmonary bypass
2000
Use of desmopressin and erythropoietin in an anaemic Jehovah’s Witness patient with severely impaired coagulation capacity undergoing stentless aortic valve replacement
2001
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Guidelines for the management of hemophilia
2012 Standout
More Effective Suppression of Hemostatic System Activation in Patients Undergoing Cardiac Surgery by Heparin Dosing Based on Heparin Blood Concentrations rather than ACT
1996
Preoperative Platelet Dysfunction Increases the Benefit of Aprotinin in Cardiopulmonary Bypass
1997
Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting. A randomized, prospective, double-blind study.
1994
Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study
2000
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
2007
Works of A Barankay being referenced
Drew-Anderson technique attenuates systemic inflammatory response syndrome and improves respiratory function after coronary artery bypass grafting
2000
High-dose aprotinin in cardiac surgery: Three years' experience in 1,784 patients
1992
Influence of combined zero-balanced and modified ultrafiltration on the systemic inflammatory response during coronary artery bypass grafting
1999
Reduction of Homologous Blood Requirement in Cardiac Surgery by Intraoperative Aprotinin Application - Clinical Experience in 152 Cardiac Surgical Patients
1989
High-dose aprotinin modulates the balance between proinflammatory and anti-inflammatory responses during coronary artery bypass graft surgery
2000
Sodium nitroprusside in patients with compromised left ventricular function undergoing coronary bypass: Reduction of cardiac proinflammatory substances
2000
Beneficial Effect of Sodium Nitroprusside After Coronary Artery Bypass Surgery: Pump Function Correlates Inversely with Cardiac Release of Proinflammatory Cytokines
2003
High-dose aprotinin application reduces homologous blood requirement in cardiac surgery
1989
Evidence for Inflammatory Responses of the Lungs During Coronary Artery Bypass Grafting With Cardiopulmonary Bypass
2001
Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations
1993
Reduction of blood utilization during myocardial revascularization
1989
[Antithrombin III substitution for optimization of the heparin effect during extracorporeal circulation in heart surgery].
1984
Influence of High-dose Aprotinin Treatment on Blood Loss and Coagulation Patterns in Patients Undergoing Myocardial Revascularization
1990
Significant leukocyte and platelet retention during pulmonary passage after declamping of the aorta in CABG patients.
1999
Plasma Troponin T and Troponin I after Minimally Invasive Coronary Bypass Surgery
2000
[Report on a partial necrosis of the tongue caused by an endotracheal tube (author's transl)].
1975
The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass
1991